Paul Poirier | Precision Medicine | Best Researcher Award

Global Scientist Day Awards

Paul Poirier
Quebec University Institute of Cardiology and Pulmonology

Paul Poirier
Affiliation Quebec University Institute of Cardiology and Pulmonology
Country Canada
Scopus ID 7006516211
Documents 473
Citations 35,166
h-index 74
Subject Area Precision Medicine
Event Global Scientist Day Awards
ORCID 0000-0002-5395-3273

Paul Poirier is a Canadian physician-scientist whose academic career has been dedicated to advancing cardiovascular medicine, obesity research, metabolic health, preventive cardiology, and precision medicine. Through extensive clinical investigation, interdisciplinary collaboration, and evidence-based practice, he has contributed substantially to understanding the interactions between cardiovascular disease, diabetes, obesity, and lifestyle interventions. His scholarly productivity and international recognition have established him as an influential researcher in cardiovascular sciences.[1]

Abstract

Paul Poirier’s research portfolio integrates clinical cardiology with precision medicine by investigating cardiovascular risk factors associated with obesity, diabetes, metabolic syndrome, exercise physiology, and preventive healthcare. His publications have significantly contributed to clinical guidelines and multidisciplinary patient management while supporting personalized therapeutic strategies across cardiovascular medicine.[1]

Keywords

Precision Medicine, Preventive Cardiology, Obesity, Cardiovascular Disease, Exercise Physiology, Diabetes, Metabolic Syndrome, Lifestyle Medicine, Clinical Research, Cardiometabolic Health.

Introduction

The increasing prevalence of obesity and metabolic disorders has emphasized the importance of precision medicine approaches in cardiovascular healthcare. Paul Poirier has played an active role in addressing these challenges through research focusing on individualized risk assessment, lifestyle modification, and evidence-based cardiovascular prevention. His work has strengthened the scientific understanding of cardiometabolic interactions and clinical management strategies.[2]

Research Profile

With more than 470 indexed scientific publications, over 35,000 citations, and an h-index of 74, Paul Poirier has established an internationally recognized research profile. His investigations encompass cardiovascular physiology, obesity medicine, diabetes management, preventive cardiology, clinical epidemiology, and precision healthcare. He has collaborated with numerous international institutions and contributed to major scientific consensus documents and clinical recommendations.[1]

Research Impact

The scientific influence of Paul Poirier is reflected through extensive citations, sustained publication output, international collaborations, and contributions to clinical practice recommendations. His work has enhanced evidence-based cardiovascular prevention and informed healthcare professionals regarding obesity-associated cardiovascular risk and precision therapeutic interventions.[3]

Award Suitability

Paul Poirier demonstrates characteristics associated with distinguished scientific achievement through sustained publication productivity, extensive scholarly influence, international collaboration, and meaningful contributions to cardiovascular medicine and precision healthcare. His research aligns with the objectives of the Global Scientist Day Awards by promoting scientific excellence, clinical innovation, and measurable improvements in patient care and public health.[1]

Conclusion

Paul Poirier has developed an internationally respected academic profile through impactful research in cardiovascular medicine, obesity, metabolic health, and precision medicine. His sustained scientific contributions continue to influence clinical practice, research collaborations, and evidence-based healthcare, making his work highly relevant within the international scientific community.

References

  1. Elsevier (2026). Scopus author details: Paul Poirier, Author ID 7006516211. Scopus.
    https://www.scopus.com/pages/authors/7006516211
  2. Pre-exercise meal macronutrient composition and acute inflammatory response in males with type 2 diabetes mellitus.
    https://doi.org/10.1161/CIRCULATIONAHA.106.171016
  3. ORCID (2026). Paul Poirier ORCID Profile.
    https://orcid.org/0000-0002-5395-3273

Marko Radulovic | Precision Medicine | Research Excellence Award

Research Excellence Award – Marko Radulovic

Marko Radulovic

Institute for Oncology and Radiology, Serbia

Marko Radulovic
Affiliation Institute for Oncology and Radiology
Country Serbia
Scholar ID 9GWuJvAAAAAJ
Documents 91
Citations 2,347
h-index 25
Subject Area Precision Medicine
Event Global Scientist Day Awards

Marko Radulovic of the Institute for Oncology and Radiology, Serbia, has established a notable academic profile through extensive research activity, a substantial publication record, and significant citation impact within the field of Precision Medicine.[1] His body of work reflects continued engagement with translational and clinical research aimed at improving healthcare outcomes through evidence-based scientific inquiry.[2]

Abstract

This article presents an academic recognition profile of Marko Radulovic in consideration for the Research Excellence Award. The assessment is based on publicly available scholarly indicators, including publication productivity, citation performance, research influence, and disciplinary engagement in Precision Medicine. With 91 indexed scholarly documents, 2,347 citations, and an h-index of 25, his academic record demonstrates sustained scientific contribution and measurable impact within oncology-related and precision healthcare research domains.[1]

Keywords

Precision Medicine; Oncology Research; Clinical Translation; Cancer Studies; Research Excellence Award; Scientific Impact; Citation Analysis; Healthcare Innovation.

Introduction

Precision Medicine has emerged as a transformative area of modern healthcare by integrating molecular biology, clinical diagnostics, and patient-specific therapeutic strategies. Researchers operating within this field contribute to the development of individualized treatment approaches that improve clinical outcomes and optimize healthcare resources.[3] Marko Radulovic’s research activities align with these objectives through scholarly work that supports evidence-based advancement in cancer diagnosis, treatment optimization, and translational medicine.[2]

Research Profile

Marko Radulovic is affiliated with the Institute for Oncology and Radiology in Serbia, an institution recognized for its involvement in cancer research and clinical care. His scholarly profile demonstrates sustained participation in scientific publishing and multidisciplinary collaboration. The available bibliometric indicators suggest broad engagement with the international scientific community and a consistent record of knowledge dissemination.[1]

  • Affiliation: Institute for Oncology and Radiology
  • Country: Serbia
  • Subject Area: Precision Medicine
  • Documents: 91
  • Citations: 2,347
  • h-index: 25

Research Contributions

The scientific contributions associated with Marko Radulovic encompass areas relevant to oncology, personalized treatment strategies, clinical research methodologies, and translational medicine. His work contributes to the understanding of disease mechanisms and supports the integration of scientific discoveries into healthcare practice.[2]

  • Advancement of precision-based clinical approaches.
  • Contribution to oncology-related scientific literature.
  • Support for evidence-driven patient management strategies.
  • Participation in collaborative and multidisciplinary research initiatives.
  • Dissemination of findings through peer-reviewed scholarly publications.

Publications

The research portfolio of Marko Radulovic includes 91 scholarly documents indexed through major academic databases. These publications collectively contribute to the advancement of knowledge in precision medicine and oncology-related disciplines.[1]

  1. Peer-reviewed research articles.
  2. Clinical and translational research studies.
  3. Collaborative multidisciplinary publications.
  4. Scientific communications addressing precision healthcare challenges.

Research Impact

Research impact may be assessed through scholarly visibility, citation performance, and influence on subsequent investigations. With 2,347 citations and an h-index of 25, Marko Radulovic’s work has demonstrated measurable recognition within the scientific community.[1] These indicators suggest that his publications have contributed to ongoing academic discourse and have informed related areas of biomedical research.[2]

Award Suitability

Based on available academic metrics and evidence of sustained scholarly activity, Marko Radulovic demonstrates characteristics commonly associated with candidates for research recognition programs. His publication record, citation influence, and contributions to precision medicine collectively support consideration for the Research Excellence Award. The combination of productivity, scientific impact, and disciplinary relevance reflects a mature and influential research profile.[1]

Conclusion

Marko Radulovic has developed a substantial academic record within the field of Precision Medicine through sustained research productivity and scholarly engagement. His documented achievements, publication output, and citation impact provide evidence of meaningful scientific contribution. These accomplishments align with the objectives of the Global Scientist Day Awards and support recognition through the Research Excellence Award.[1]

References

  1. Google Scholar. (n.d.). Marko Radulovic Citation Profile and Scholarly Metrics. Google Scholar. https://scholar.google.com/citations?user=9GWuJvAAAAAJ&hl=en&oi=ao
  2. Discriminative Pattern Mining for Breast Cancer Histopathology Image Classification via Fully Convolutional Autoencoder.
    https://ieeexplore.ieee.org/abstract/document/8664469
  3. Pharmacology and Biology of Corticotropin-Releasing Factor (CRF) Receptors.
    https://www.tandfonline.com/doi/abs/10.3109/10606820213678
  4. Corticotropin-Releasing Factor Receptor 1 in Mouse Spleen: Expression After Immune Stimulation and Identification of Receptor-Bearing Cells. https://academic.oup.com/jimmunol/article-abstract/162/5/3013/8041238

Taeyoung Kyong | Medical Discoveries | Research Excellence Award

Prof. Taeyoung Kyong | Medical Discoveries | Research Excellence Award

Yonsei University College of Medicine | South Korea

Professor Taeyoung Kyong is a distinguished hospitalist and academic at Yonsei University College of Medicine, specializing in internal medicine and diabetes care. His work focuses on hospitalist-led care models that enhance glycemic control, patient safety, and care transitions in inpatient settings. He has led and contributed to impactful clinical research, published extensively in indexed journals, and served as a reviewer for international medical journals. Through collaborations with leading hospitals and medical technology firms, he integrates digital health and AI-driven monitoring into clinical practice, advancing evidence-based hospital medicine and improving outcomes for patients with chronic diseases.
View Orcid Profile

Featured Publications

Simon Podnar | Medical Discoveries | Research Excellence Award

Prof. Simon Podnar | Medical Discoveries | Research Excellence Award

University Medical Centre Ljubljana | Slovenia

Prof. Simon Podnar, MD, DSc, is a distinguished neurologist and clinical neurophysiologist at the University of Ljubljana and the University Medical Center Ljubljana. He specializes in electromyography, neuromuscular imaging, and advanced neurophysiological diagnostics, with international training across Europe and the United States. He introduced neuromuscular ultrasonography to Slovenia and has held major leadership roles in national and international neurological societies. He leads Slovenia’s only state-funded clinical neurological research program, serves on leading journal editorial boards, and has authored over 400 scientific works, including influential discoveries in neuromuscular and peripheral nerve disorders.

Citation Metrics (Scopus)

4000
3000
2000
1000
0

Citations
2,724

Documents
132

h-index
30

Citations

Documents

h-index


View Scopus Profile
View Orcid Profile
View Google Scholar Profile

Featured Publications

Chien-Hung Yeh | Research Excellence | Best Researcher Award

Prof. Dr. Chien-Hung Yeh | Research Excellence | Best Researcher Award

Prof. Dr. Chien-Hung Yeh | Beijing Institute of Technology, China

Professor Chien-Hung Yeh, a tenured faculty member at Beijing Institute of Technology and a National High-Level Fellow, is renowned for his groundbreaking work in neuromodulation, cross-frequency coupling, and medical AI. With over 50 SCI publications, 15+ patents, and leadership in major national research projects, he has significantly advanced intelligent healthcare technologies. His collaborations span prestigious institutions like Harvard and Oxford, and his innovations influence clinical practices and brain-computer interface development. As a senior IEEE member and editorial board contributor, Professor Yeh exemplifies excellence in interdisciplinary biomedical engineering—making him a distinguished candidate for the Best Researcher Award.

Academic Profile 

ORCID, Google Scholar

Education

Professor Chien-Hung Yeh holds a distinguished academic background, earning his doctoral degree through a joint supervision program between Harvard Medical School and National Central University. This unique cross-continental academic training provided him with a rich blend of cutting-edge biomedical knowledge and rigorous technological insight. His PhD research laid the groundwork for his later innovations in neuromodulation and cross-frequency coupling, with strong emphasis on translational science bridging engineering and clinical neuroscience. His academic journey reflects both depth and global perspective, equipping him with interdisciplinary tools essential for leadership in advanced healthcare technologies.

Experience

Professor Yeh currently serves as a tenured professor at Beijing Institute of Technology, one of China’s premier research universities. Over the years, he has gained extensive experience leading major national-level research projects, including initiatives funded by the Ministry of Science and Technology of China, the National Natural Science Foundation of China (NSFC), and the Beijing Municipal Health Commission. In addition to his academic role, he is actively engaged in consultancy and industry-academia collaborations, such as with Kao Corporation and Neuracle Technology Co., Ltd. He also chairs IEEE conferences and serves as a reviewer for various high-level funding agencies including the Ministry of Industry and Information Technology and the National Science Foundation of China. His experience spans administration, research management, teaching, and policy advising, making him a key figure in biomedical innovation ecosystems.

Research Interests

Professor Yeh’s research is at the forefront of biomedical engineering, with core interests in cross-frequency coupling, neuromodulation, and artificial intelligence applications in medicine. He is internationally recognized for his pioneering work on dynamic brain signal processing, particularly in the development of algorithms for brain-computer interfaces and intelligent monitoring systems for neurological disorders. His contributions to waveform analysis and AI-driven health diagnostics have practical implications for epilepsy, Parkinson’s disease, sleep disorders, and critical care. These interests are not only intellectually rigorous but also clinically transformative, aiming to close the gap between neuroscience theory and patient-centered innovation.

Awards

Throughout his career, Professor Yeh has received numerous prestigious recognitions. He has been honored as a National High-Level Fellow in China, a designation reserved for top-tier scientists making significant contributions to strategic research areas. His projects have received substantial support from national and municipal government bodies, reinforcing the value of his work to public health and innovation policy. He has also co-led a team that was named a runner-up in the Qualcomm Tricorder XPRIZE, a global competition to develop portable diagnostic devices capable of revolutionizing healthcare delivery. This accomplishment highlights the global applicability of his research. Furthermore, Professor Yeh’s editorial roles in leading journals, including Cyborg and Bionic Systems, Applied Sciences, and BMC Medical Informatics and Decision Making, along with his membership in key professional societies such as IEEE and the Chinese Society of Biomedical Engineering, reflect the academic community’s high regard for his expertise and leadership.

Publications

Amplitude modulation multiscale entropy characterizes complexity and brain states

Author: W Shi, H Feng, X Zhang, CH Yeh
Journal: Chaos, Solitons & Fractals
Year: 2023

A novel measure of cardiopulmonary coupling during sleep based on the synchrosqueezing transform algorithm 

Author: Y Wang, W Shi, CH Yeh
Journal: IEEE journal of biomedical and health informatics
Year: 2023

Waveform changes with the evolution of beta bursts in the human subthalamic nucleus

Author: CH Yeh, B Al-Fatly, AA Kuehn, AC Meidahl, G Tinkhauser, H Tan,
Journal: Clinical neurophysiology
Year: 2020

Generalized multiscale Lempel–Ziv complexity of cyclic alternating pattern during sleep

Author: CH Yeh, W Shi
Journal: Nonlinear Dynamics
Year: 2018

A comparison study on stages of sleep: Quantifying multiscale complexity using higher moments on coarse-graining

Author: W Shi, P Shang, Y Ma, S Sun, CH Yeh
Journal: Communications in Nonlinear Science and Numerical Simulation
Year: 2017

Quantifying spasticity with limited swinging cycles using pendulum test based on phase amplitude coupling

Author: CH Yeh, HWV Young, CY Wang, YH Wang, PL Lee, JH Kang, MT Lo
Journal: IEEE Transactions on Neural Systems and Rehabilitation Engineering
Year: 2016

Spurious cross-frequency amplitude–amplitude coupling in nonstationary, nonlinear signals

Author: CH Yeh, MT Lo, K Hu
Journal: Physica A: Statistical Mechanics and its Applications
Year: 2016

On the computational complexity of the empirical mode decomposition algorithm 

Author: YH Wang, CH Yeh, HWV Young, K Hu, MT Lo
Journal: Physica A: Statistical Mechanics and its Applications
Year: 2014

Conclusion

Professor Chien-Hung Yeh exemplifies the ideal candidate for the Best Researcher Award through his high-impact publications, transformative research, interdisciplinary expertise, and technological innovations. His leadership in both academic and applied research domains, coupled with international collaborations and continuous contributions to scientific advancement, makes him a deserving recipient of this recognition.

Haishan Jiang | Medical Discoveries | Innovation in Science Award

Dr. Haishan Jiang | Medical Discoveries | Innovation in Science Award 

Dr. Haishan Jiang, Southern Medical University, China

Dr. Haishan Jiang, Chief Physician and Associate Professor at Southern Medical University’s Nanfang Hospital, is a leading expert in neurology, specializing in myopathy, peripheral neuropathy, and rare neurological diseases. As Deputy Director of the Neurology Department and head of the Myopathy and Peripheral Neuropathy subspecialty, he has pioneered gene therapies for SMA and ALS in South China. His research focuses on motor neuron and mitochondrial diseases, as well as gene therapy for rare conditions. Widely recognized, Dr. Jiang has been honored as the “Good Doctor of Guangzhou” and ranks top nationally in physician recommendations for multiple rare diseases.

Author Profile

ORCID

🧑‍🎓 Early Academic Pursuits

Dr. Haishan Jiang embarked on his medical journey with a deep-rooted commitment to understanding the complexities of the human nervous system. With a Doctor of Medicine degree and solid academic grounding, he demonstrated early on a keen interest in neurology, particularly in the areas of myopathy and peripheral neuropathy. His academic path was marked by diligence, a sharp scientific mind, and a profound dedication to uncovering the underlying mechanisms of rare neurological diseases. As a postgraduate supervisor, Dr. Jiang has also shown a strong passion for nurturing the next generation of medical professionals, sharing his knowledge and guiding their research pursuits with patience and precision.

🩺 Professional Endeavors

Currently serving at Nanfang Hospital of Southern Medical University, Dr. Jiang holds several key positions: Chief Physician, Associate Professor, Deputy Director of the Neurology Department, Director of Teaching, and Head of the Myopathy and Peripheral Neuropathy subspecialty. His clinical expertise spans a wide spectrum of neurological disorders, with a particular emphasis on difficult and rare conditions such as motor neuron disease (ALS), mitochondrial encephalomyopathy, and adult-onset spinal muscular atrophy (SMA). Dr. Jiang’s commitment to clinical excellence has led him to establish and lead the Guangdong Province Myopathy and Peripheral Nerve Specialized Alliance, a network aimed at advancing diagnosis, treatment, and research collaboration. Under his leadership, the department ranks among the top two nationally in terms of annual muscle and nerve biopsy volume, solidifying its reputation as a hub for neuromuscular disease care.

🧬 Contributions and Research Focus

Dr. Jiang’s research interests are firmly rooted in neurogenetic disorders, particularly motor neuron diseases (ALS) and mitochondrial disorders. His work seamlessly blends basic science with clinical application, focusing on understanding disease mechanisms and exploring cutting-edge gene therapy approaches. He has spearheaded some of South China’s most advanced gene therapy trials, including the region’s first gene therapy for adult SMA—the fourth such case in the country—and the first ALS gene therapy clinical trial in South China, also the second nationwide. His pioneering research not only contributes to academic knowledge but also offers hope to patients battling previously untreatable conditions. Through his clinical studies, Dr. Jiang is pushing the frontiers of personalized medicine, bringing precision diagnostics and therapy into the mainstream for rare and complex neurological diseases.

🏅 Accolades and Recognition

Dr. Haishan Jiang’s unwavering dedication to medical science and patient care has earned him widespread acclaim. Notably, he was honored as the sixth “Good Doctor of Guangzhou” and selected as part of the ninth batch of “Outstanding Provincial and Municipal Talents Supporting Xinjiang”, a testament to both his clinical excellence and humanitarian spirit. Furthermore, he was recognized by the Good Doctor Network as an “Annual Good Doctor” for his exceptional service in rare disease diagnosis and treatment. His reputation as a leading clinician is reflected in his top rankings in national physician recommendation lists—first place for 13 diseases, including ALS and mitochondrial encephalomyopathy, and second place for 15 others. These accolades not only highlight his expertise but also the trust he has earned from patients and peers alike.

🌍 Impact and Influence

Dr. Jiang’s work has had a transformative impact on neurology in China, particularly in the realm of rare diseases. By advancing the use of gene therapy and establishing regional alliances, he has created a robust infrastructure for collaboration, research, and clinical care. His contributions have significantly improved diagnostic timelines and therapeutic options for patients who previously faced long diagnostic odysseys and limited treatment possibilities. As a teacher and mentor, Dr. Jiang has shaped the careers of countless postgraduate students and young doctors, many of whom now contribute to clinical neurology and research across the country. His influence extends beyond the clinic to policy and advocacy, where he is a strong voice for the rare disease community.

🔬 Legacy and Future Contributions

Dr. Haishan Jiang stands at the forefront of a new era in neurology, where genomics and personalized medicine are reshaping how we understand and treat complex diseases. His legacy is already evident in the systems he has built, the patients he has helped, and the students he has inspired. Looking ahead, Dr. Jiang aims to further expand gene therapy applications, develop innovative treatment protocols, and foster international collaboration in rare disease research. With his continued focus on combining scientific rigor with compassionate care, Dr. Jiang is set to leave a lasting legacy in Chinese and global neurology. His work is not only rewriting the medical narrative for patients with rare conditions but also paving the way for future breakthroughs in neuroscience.

✍️ Publication Top Notes


📘A Multicenter Study of Hereditary Transthyretin Amyloidosis in China

Author: Xujun Chu; Juan Kang; Jingwen Xu; Haishan Jiang; Zhi‐Ying Wu; Qingping Wang; Wei Li; Jia Li;
Journal: Annals of Neurology
Year:2025

📘Knockdown of OPTN modulates miRNA-125b-5p expression via NF-κB pathways in amyotrophic lateral sclerosis

Author: Jian Qin; Ye He; Weiyi Yu; Zhaoyong Zhang; Xiaodan Chen; Yafang Hu; Haishan Jiang
Journal: Archives of Biochemistry and Biophysics
Year: 2025

📘Clinical features of hereditary transthyretin amyloidosis-polyneuropathy with transthyretin Ala97Ser(p.Ala117Ser) mutation in South Mainland China

Author: Yeli Zhu; Jingxian Fan; Xiying Zhu; Wei Li; Zhaoyong Zhang; Hui Zheng; Zhihua Zhou; Lingchao Meng; Ruxu Zhang; Haishan Jiang
Journal: Orphanet Journal of Rare Diseases
Year: 2025